Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

McVie-Veronesi Award Lecture “The quest to deliver a balance between the best care and Choosing Wisely”

Dr Anita Borges - S L Raheja Hospital, Mumbai, India
McVie-Veronesi Award Lecture “The quest to deliver a balance between the best care and Choosing Wisely” ( Dr Anita Borges -  S L Raheja Hospital, Mumbai, India )
21 Sep 2024

Weaving in Choosing Wisely, Common Sense Oncology in all aspects of global health

Dr Christopher Booth - Queen's University, Kingston, Canada
Weaving in Choosing Wisely, Common Sense Oncology in all aspects of global health ( Dr Christopher Booth - Queen's University, Kingston, Canada )
21 Sep 2024

ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer

Prof Karim Fizazi, Dr Anders Bjartell, Dr Niven Mehra and Prof Eleni Efstathiou
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer ( Prof Karim Fizazi, Dr Anders Bjartell, Dr Niven Mehra and Prof Eleni Efstathiou )
19 Sep 2024

ESMO 2024: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2024: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )
16 Sep 2024

ESMO 2024: Latest in EGFR mutated NSCLC

Prof Ignacio Gil-Bazo, Dr Mariana Brandão, Prof Benjamin Besse and Prof Enriqueta Felip
ESMO 2024: Latest in EGFR mutated NSCLC ( Prof Ignacio Gil-Bazo, Dr Mariana Brandão, Prof Benjamin Besse and Prof Enriqueta Felip )
16 Sep 2024

Understanding the use of PARPi combinations to treat patients with mCRPC

Prof Axel Merseburger, Dr Friederike Schlurmann, Dr Elena Castro and Prof Gerhardt Attard
Understanding the use of PARPi combinations to treat patients with mCRPC ( Prof Axel Merseburger, Dr Friederike Schlurmann, Dr Elena Castro and Prof Gerhardt Attard )
15 Sep 2024

ESMO 2024: Optimising the personalisation of prostate cancer treatment

Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg
ESMO 2024: Optimising the personalisation of prostate cancer treatment ( Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg )
15 Sep 2024

Trastuzumab deruxtecan effective against brain metastases in HER2-positive breast cancer

Dr Nancy Lin - Dana-Farber Cancer Institute, Boston, USA
Trastuzumab deruxtecan effective against brain metastases in HER2-positive breast cancer ( Dr Nancy Lin - Dana-Farber Cancer Institute, Boston, USA )
14 Sep 2024

The promise of CAR T cell therapy for multiple myeloma

Dr Dibakar Podder - Tata Medical Center, Kolkata, India
The promise of CAR T cell therapy for multiple myeloma ( Dr Dibakar Podder - Tata Medical Center, Kolkata, India )
8 Sep 2024

Colon cancer and mental health

Prof V Surendran- Cancer Institute, Chennai, India
Colon cancer and mental health ( Prof V Surendran- Cancer Institute, Chennai, India )
7 Sep 2024

Positive data for the use of radioligand therapy in first-line neuroendocrine cancers

Dr Simron Singh - University of Toronto, Toronto, Canada
Positive data for the use of radioligand therapy in first-line neuroendocrine cancers ( Dr Simron Singh - University of Toronto, Toronto, Canada )
21 Aug 2024

Multiple myeloma In Rwanda: The need for further research

Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda
Multiple myeloma In Rwanda: The need for further research ( Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda )
6 Aug 2024